Logo image of INST

Instructure Holdings Inc (INST) Stock Fundamental Analysis

NYSE:INST - New York Stock Exchange, Inc. - US4577901030 - Common Stock - Currency: USD

23.6  +0.02 (+0.08%)

After market: 25 +1.4 (+5.93%)

Fundamental Rating

3

INST gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. INST has a bad profitability rating. Also its financial health evaluation is rather negative. INST is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

INST had positive earnings in the past year.
In the past year INST had a positive cash flow from operations.
INST had negative earnings in each of the past 5 years.
INST had a positive operating cash flow in 4 of the past 5 years.
INST Yearly Net Income VS EBIT VS OCF VS FCFINST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.80%, INST is in line with its industry, outperforming 57.14% of the companies in the same industry.
INST has a Return On Equity (-4.19%) which is in line with its industry peers.
INST has a Return On Invested Capital of 1.27%. This is in the better half of the industry: INST outperforms 66.07% of its industry peers.
Industry RankSector Rank
ROA -1.8%
ROE -4.19%
ROIC 1.27%
ROA(3y)-2.44%
ROA(5y)-7.63%
ROE(3y)-4.1%
ROE(5y)-17.24%
ROIC(3y)N/A
ROIC(5y)N/A
INST Yearly ROA, ROE, ROICINST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

With a decent Operating Margin value of 6.68%, INST is doing good in the industry, outperforming 73.57% of the companies in the same industry.
The Gross Margin of INST (66.28%) is comparable to the rest of the industry.
INST's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.68%
PM (TTM) N/A
GM 66.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.8%
GM growth 5Y-1.48%
INST Yearly Profit, Operating, Gross MarginsINST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INST is destroying value.
Compared to 1 year ago, INST has more shares outstanding
INST has more shares outstanding than it did 5 years ago.
The debt/assets ratio for INST has been reduced compared to a year ago.
INST Yearly Shares OutstandingINST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
INST Yearly Total Debt VS Total AssetsINST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

INST has an Altman-Z score of 1.28. This is a bad value and indicates that INST is not financially healthy and even has some risk of bankruptcy.
INST has a Altman-Z score of 1.28. This is in the lower half of the industry: INST underperforms 62.50% of its industry peers.
INST has a debt to FCF ratio of 10.83. This is a negative value and a sign of low solvency as INST would need 10.83 years to pay back of all of its debts.
INST has a Debt to FCF ratio (10.83) which is in line with its industry peers.
A Debt/Equity ratio of 0.90 indicates that INST is somewhat dependend on debt financing.
INST has a worse Debt to Equity ratio (0.90) than 74.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 10.83
Altman-Z 1.28
ROIC/WACC0.11
WACC12.02%
INST Yearly LT Debt VS Equity VS FCFINST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

INST has a Current Ratio of 0.92. This is a bad value and indicates that INST is not financially healthy enough and could expect problems in meeting its short term obligations.
INST's Current ratio of 0.92 is on the low side compared to the rest of the industry. INST is outperformed by 77.86% of its industry peers.
INST has a Quick Ratio of 0.92. This is a bad value and indicates that INST is not financially healthy enough and could expect problems in meeting its short term obligations.
INST's Quick ratio of 0.92 is on the low side compared to the rest of the industry. INST is outperformed by 77.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.92
INST Yearly Current Assets VS Current LiabilitesINST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.64% over the past year.
Looking at the last year, INST shows a quite strong growth in Revenue. The Revenue has grown by 11.58% in the last year.
The Revenue has been growing by 20.41% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)9.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8%
Revenue 1Y (TTM)11.58%
Revenue growth 3Y20.62%
Revenue growth 5Y20.41%
Sales Q2Q%28.34%

3.2 Future

Based on estimates for the next years, INST will show a small growth in Earnings Per Share. The EPS will grow by 7.25% on average per year.
Based on estimates for the next years, INST will show a quite strong growth in Revenue. The Revenue will grow by 14.05% on average per year.
EPS Next Y0.86%
EPS Next 2Y4.72%
EPS Next 3Y7.25%
EPS Next 5YN/A
Revenue Next Year25.44%
Revenue Next 2Y17.22%
Revenue Next 3Y14.05%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
INST Yearly Revenue VS EstimatesINST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
INST Yearly EPS VS EstimatesINST Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 25.93, the valuation of INST can be described as expensive.
Based on the Price/Earnings ratio, INST is valued a bit cheaper than 77.50% of the companies in the same industry.
INST's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.30.
INST is valuated quite expensively with a Price/Forward Earnings ratio of 25.02.
Based on the Price/Forward Earnings ratio, INST is valued a bit cheaper than the industry average as 74.64% of the companies are valued more expensively.
INST is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.93
Fwd PE 25.02
INST Price Earnings VS Forward Price EarningsINST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, INST is valued a bit cheaper than 80.00% of the companies in the same industry.
77.14% of the companies in the same industry are more expensive than INST, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 30.89
EV/EBITDA 22.44
INST Per share dataINST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates INST does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)30.19
PEG (5Y)N/A
EPS Next 2Y4.72%
EPS Next 3Y7.25%

0

5. Dividend

5.1 Amount

No dividends for INST!.
Industry RankSector Rank
Dividend Yield N/A

Instructure Holdings Inc

NYSE:INST (11/12/2024, 8:11:18 PM)

After market: 25 +1.4 (+5.93%)

23.6

+0.02 (+0.08%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-08 2024-11-08/amc
Earnings (Next)N/A N/A
Inst Owners98.16%
Inst Owner Change0%
Ins Owners6.07%
Ins Owner Change0%
Market Cap3.47B
Analysts52.31
Price Target24.21 (2.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.76%
Min EPS beat(2)15.15%
Max EPS beat(2)46.37%
EPS beat(4)3
Avg EPS beat(4)20.51%
Min EPS beat(4)-0.74%
Max EPS beat(4)46.37%
EPS beat(8)5
Avg EPS beat(8)9.19%
EPS beat(12)9
Avg EPS beat(12)20.77%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.65%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)0%
Revenue beat(4)0
Avg Revenue beat(4)-0.74%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)0%
Revenue beat(8)2
Avg Revenue beat(8)-0.31%
Revenue beat(12)6
Avg Revenue beat(12)0.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.56%
EPS NQ rev (1m)0.1%
EPS NQ rev (3m)0.19%
EPS NY rev (1m)-0.11%
EPS NY rev (3m)-0.11%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-0.03%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 25.93
Fwd PE 25.02
P/S 5.82
P/FCF 30.89
P/OCF 29.13
P/B 2.73
P/tB N/A
EV/EBITDA 22.44
EPS(TTM)0.91
EY3.86%
EPS(NY)0.94
Fwd EY4%
FCF(TTM)0.76
FCFY3.24%
OCF(TTM)0.81
OCFY3.43%
SpS4.05
BVpS8.65
TBVpS-8.15
PEG (NY)30.19
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.8%
ROE -4.19%
ROCE 1.6%
ROIC 1.27%
ROICexc 1.34%
ROICexgc N/A
OM 6.68%
PM (TTM) N/A
GM 66.28%
FCFM 18.85%
ROA(3y)-2.44%
ROA(5y)-7.63%
ROE(3y)-4.1%
ROE(5y)-17.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.8%
GM growth 5Y-1.48%
F-Score4
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 10.83
Debt/EBITDA 5.62
Cap/Depr 4.17%
Cap/Sales 1.14%
Interest Coverage 0.61
Cash Conversion 58.77%
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.92
Altman-Z 1.28
F-Score4
WACC12.02%
ROIC/WACC0.11
Cap/Depr(3y)3.87%
Cap/Depr(5y)13.03%
Cap/Sales(3y)1.17%
Cap/Sales(5y)1.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8%
EPS Next Y0.86%
EPS Next 2Y4.72%
EPS Next 3Y7.25%
EPS Next 5YN/A
Revenue 1Y (TTM)11.58%
Revenue growth 3Y20.62%
Revenue growth 5Y20.41%
Sales Q2Q%28.34%
Revenue Next Year25.44%
Revenue Next 2Y17.22%
Revenue Next 3Y14.05%
Revenue Next 5YN/A
EBIT growth 1Y477.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.52%
EBIT Next 3Y16.91%
EBIT Next 5YN/A
FCF growth 1Y19.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.16%
OCF growth 3YN/A
OCF growth 5Y339.52%